U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07809646) titled 'Cl-Pharm-IBS-ML-2026' on Sept. 03.
Brief Summary: The purpose of this study is to identify distinct subgroups (phenotypes) of Irritable Bowel Syndrome (IBS) patients. While traditional IBS classification relies mainly on bowel habits, this research uses a multidimensional questionnaire to capture clinical symptoms, psychological factors, diet triggers, sleep quality, and digital behaviors. By applying advanced machine learning algorithms to these patient-reported outcomes, the study aims to uncover hidden patterns that can help customize future treatments and improve patient care.
Study Start Date: Sept. 20
Study Type: OBSERVATIO...